Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Study 2015-2025, by Segment (Exenatied, Liraglutide, Lixisenatide), by Market (Hospital, PharmacyLiraglutide, Others), by Company (Novo Nordisk, AstraZeneca, Eli Lily)

ReportPage
Report ID
48882
Published Date
23-Sep
No of Report Page
78
Report Category
Editor's Rating
US $3,600.00
US $3,600.00
US $1,800.00

  • Report Details

    Snapshot
    Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
    The global Glucagon Like Peptide-1 (GLP-1) Agonists market will reach xxx Million USD in 2018

    More...
  • Table Of Content

    Table of Content
    1 Industry Overview
    1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry
    1.1.1 Overview
    1.1.2 Products of Major Companies
    1.2 Market Segment
    1.2.1 Industry Chain
    1.2.2 Consumer Distribution
    1.3 Price & Cost Overview
    2 Glucagon Like Peptide-1 (GLP-1) Agonists Market by Type
    2.1 By Type
    2.1.1 Exenatied
    2.1.2 Liraglutide

    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample